RNAi of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase.

[1]  Nobutaka Hattori,et al.  14‐3‐3η is a novel regulator of parkin ubiquitin ligase , 2006, The EMBO journal.

[2]  N. Hayashi,et al.  Deletion of N‐terminus of human tyrosine hydroxylase type 1 enhances stability of the enzyme in AtT‐20 cells , 2005, Journal of neuroscience research.

[3]  L. Tsai,et al.  Cyclin-dependent Kinase 5 Phosphorylates Serine 31 of Tyrosine Hydroxylase and Regulates Its Stability* , 2004, Journal of Biological Chemistry.

[4]  T. Iwatsubo,et al.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Flatmark,et al.  Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. , 2002, European journal of biochemistry.

[6]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Nomura,et al.  Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. , 1999, Biochemistry.

[8]  L. Petrucelli,et al.  α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.

[9]  P. Fitzpatrick,et al.  Limited proteolysis of tyrosine hydroxylase identifies residues 33-50 as conformationally sensitive to phosphorylation state and dopamine binding. , 1999, Archives of biochemistry and biophysics.

[10]  Raymond C. Stevens,et al.  Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases , 1997, Nature Structural Biology.

[11]  S. Rogers,et al.  PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.

[12]  R. Roskoski,et al.  Thermal stability and CD analysis of rat tyrosine hydroxylase. , 1995, Biochemistry.

[13]  H. Fujisawa,et al.  Conversion of Tyrosine Hydroxylase to Stable and Inactive Form by the End Products , 1991, Journal of neurochemistry.

[14]  T. Isobe,et al.  Brain 14‐3‐3 protein is an activator protein that activates tryptophan 5‐monooxygenase and tyrosine 3‐monooxygenase in the presence of Ca2+,calmodulin‐dependent protein kinase II , 1987, FEBS letters.

[15]  S. Rogers,et al.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. , 1986, Science.

[16]  K. Mori,et al.  Expression of human tyrosine hydroxylase type I in Escherichia coli as a protease-cleavable fusion protein , 1999, Journal of Neural Transmission.

[17]  T. Flatmark,et al.  The effect of phosphorylation at Ser-40 on the structure and thermal stability of tyrosine hydroxylase. , 1998, Advances in pharmacology.